http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2500371-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e51a279fa3515d1e152f2e1f0d8f9b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81ec7de632904bae8cd4509867f846f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac05ac3c3a238014d7123453aa21bb4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_644f96af2e73669b92e154e8014520b4 |
| publicationDate | 2013-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2500371-C1 |
| titleOfInvention | Method of treating secondary glaucoma, induced by silicone emulgation |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to field of medicine, namely to ophthalmology, and can be used for treatment of secondary glaucoma after performing subtotal vitrectomy with introduction of silicone oil after retinal detachment. Superficial sclera flap is formed. Application of mitomycin C in dos 0.1 ml with concentration 0.2-0.5 mg/ml is performed onto internal surface of superficial flap for 1-5 minutes before ablation of middle layers of sclera. Ablation of middle layers of sclera is carried out to limbal layers of cornea. Needle 27G is introduced under sclera flap in the area of limbus, in the centre of cut out flap, and used to introduce 0.1-0.3 ml of viscoelastic into anterior chamber. Needle is removed and drainage Ex-press Shunt Model P 200 (Alcon, the USA) is installed into anterior chamber by means of injector. Operation is completed. Injections of 5-fluoruracyl in dose 0.1-0.2 ml are performed into filtering bleb subconjunctivally on the first day and further one time per week for 5-7 days. n EFFECT: method ensures preservation of visual functions, recovery of tracts for intraocular fluid outflow, and the most complete removal of emulsified silicone from anterior chamber. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2790760-C1 |
| priorityDate | 2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.